{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T22:45:07Z","timestamp":1777157107004,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s40263-024-01065-4","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T10:02:26Z","timestamp":1706176946000},"page":"225-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early Experiences with Intrathecal Administration of Amphotericin B Liposomal Formulation at a Neurosurgical Center"],"prefix":"10.1007","volume":"38","author":[{"given":"Michael D.","family":"Nailor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9736-0891","authenticated-orcid":false,"given":"Kellie J.","family":"Goodlet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Tyler","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"1065_CR1","first-page":"519","volume":"64","author":"J Ho","year":"2017","unstructured":"Ho J, Fowler P, Heidari A, Johnson RH. Intrathecal amphotericin B: a 60-year experience in treating coccidioidal meningitis. Clin Infect Dis. 2017;64:519\u201324.","journal-title":"Clin Infect Dis"},{"key":"1065_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/myc.13534","volume":"66","author":"AN Magdalany","year":"2023","unstructured":"Magdalany AN, Nailor MD, Gonzalez O, Goodlet KJ. Can fluconazole be used for inpatient re-treatment of coccidioidomycosis among patients with past fluconazole exposures? Mycoses. 2023;66:150\u20136.","journal-title":"Mycoses"},{"key":"1065_CR3","unstructured":"Centers for Disease Control and Prevention. Fungal meningitis outbreak associated with procedures performed under epidural anesthesia in Matamoros, Mexico. Available at https:\/\/www.cdc.gov\/hai\/outbreaks\/meningitis-epidural-anesthesia.html. Accessed 21 Sep 2023."},{"key":"1065_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad570","author":"DJ Smith","year":"2023","unstructured":"Smith DJ, Gold JAW, Chiller T, et al. Update on outbreak of fungal meningitis among U.S. residents who received epidural anesthesia at two clinics in Matamoros, Mexico. Clin Infect Dis. 2023. https:\/\/doi.org\/10.1093\/cid\/ciad570. (Epub ahead of print).","journal-title":"Clin Infect Dis"},{"key":"1065_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1128\/AAC.45.2.612-615.2001","volume":"45","author":"KV Clemons","year":"2001","unstructured":"Clemons KV, Sobel RA, Williams PL, Stevens DA. Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits. Antimicrob Agents Chemother. 2001;45:612\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1065_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijantimicag.2011.10.014","volume":"39","author":"AF Gazzoni","year":"2012","unstructured":"Gazzoni AF, Capilla J, Mayayo E, Guarro J. Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis. Int J Antimicrob Agents. 2012;39:223\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"1065_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijantimicag.2013.04.032","volume":"42","author":"J Capilla","year":"2013","unstructured":"Capilla J, Flavia A, Mayayo E, Guarro J. Efficacy of intrathecal liposomal amphotericin B plus oral posaconazole in the treatment of acute meningeal cryptococcosis in a murine model. Int J Antimicrob Agents. 2013;42:282\u20133.","journal-title":"Int J Antimicrob Agents"},{"key":"1065_CR8","first-page":"77","volume":"55","author":"G Alvarez-Uria","year":"2018","unstructured":"Alvarez-Uria G, Midde M, Battula J, Pujari HNB. Safety and tolerability of intrathecal liposomal amphotericin B (AmBisome) for cryptococcal meningitis: a retrospective study in HIV-infected patients. Ther Adv Infect Dis. 2018;55:77\u201381.","journal-title":"Ther Adv Infect Dis."},{"key":"1065_CR9","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.jocn.2014.01.008","volume":"21","author":"BL Grannan","year":"2014","unstructured":"Grannan BL, Yanamadala V, Venteicher AS, Walcott BP, Barr JC. Use of external ventriculostomy and intrathecal anti-fungal treatment in cerebral mucormycotic abscess. J Clin Neurosci. 2014;21:1819\u201321.","journal-title":"J Clin Neurosci"},{"key":"1065_CR10","volume":"2015","author":"D Toprak","year":"2015","unstructured":"Toprak D, \u00d6cal Demir S, Kadayifci EK, T\u00fcrel \u00d6, Soysal A, Bakir M. Recurrent Candida albicans ventriculitis treated with intraventricular liposomal amphotericin B. Case Rep Infect Dis. 2015;2015: 340725.","journal-title":"Case Rep Infect Dis"},{"key":"1065_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clineuro.2019.03.019","volume":"181","author":"B Fiani","year":"2019","unstructured":"Fiani B, Nguyen A, Quadri SA, et al. Trending serial CSF samples to guide treatment of refractory coccidioidal meningitis with intrathecal liposomal amphotericin. Clin Neurol Neurosurg. 2019;181:41\u20133.","journal-title":"Clin Neurol Neurosurg"},{"key":"1065_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jgar.2020.03.016","volume":"22","author":"AFAD Schauwvlieghe","year":"2020","unstructured":"Schauwvlieghe AFAD, Bredius RGM, Verdijk RM, et al. Management of cerebral azole-resistant Aspergillus fumigatus infection: a role for intraventricular liposomal-amphotericin B. J Glob Antimicrob Resist. 2020;22:354\u20137.","journal-title":"J Glob Antimicrob Resist"},{"key":"1065_CR13","doi-asserted-by":"publisher","first-page":"e00190","DOI":"10.1128\/CMR.00190-19","volume":"33","author":"R Nau","year":"2020","unstructured":"Nau R, Blei C, Eiffert H. Intrathecal antibacterial and antifungal therapies. Clin Microbiol Rev. 2020;33:e00190-e219.","journal-title":"Clin Microbiol Rev"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01065-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01065-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01065-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T19:09:28Z","timestamp":1710097768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01065-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01065-4","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"9 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by no internal or external sources of funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"M.D.N. has served as a consultant for Shionogi, AbbVie, and Merck. K.J.G., O.G., and J.T.H. have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}},{"value":"The datasets generated during and\/or analysed during the current study are not publicly available due to the inclusion of protected health information but are available from the corresponding author on reasonable request pursuant to a data use agreement.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes and was approved by the Institutional Review Board (IRB) of St. Joseph\u2019s Hospital and Medical Center (PHX-24-500-022-71-47). The IRB has determined the request for waiver of informed consent as described within the submission satisfies the criteria for approval under 45 CFR 46.116(f)(3).","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"M.D.N. carried out the conceptualization, methodology, and writing\u2014review and editing; K.J.G. carried out the investigation and writing\u2014original draft; O.G. created the methodology and carried out the writing\u2014review and editing; and J.T.H. created the methodology and carried out the writing\u2014review and editing.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}